These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10228618)

  • 1. Abdominal vessel enhancement with an ultrasmall, superparamagnetic iron oxide blood pool agent: evaluation of dose and echo time dependence at different field strengths.
    Wikström LJ; Johansson LO; Ericsson BA; Börseth A; Akeson PA; Ahlström KH
    Acad Radiol; 1999 May; 6(5):292-8. PubMed ID: 10228618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
    Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
    Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
    Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Jhooti P; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 1999; 1(1):23-32. PubMed ID: 11550338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study.
    Ahlström KH; Johansson LO; Rodenburg JB; Ragnarsson AS; Akeson P; Börseth A
    Radiology; 1999 Jun; 211(3):865-9. PubMed ID: 10352617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional cardiac cine magnetic resonance imaging with an ultrasmall superparamagnetic iron oxide blood pool agent (NC100150).
    Amano Y; Herfkens RJ; Shifrin RY; Alley MT; Pelc NJ
    J Magn Reson Imaging; 2000 Feb; 11(2):81-6. PubMed ID: 10713938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide.
    Mayo-Smith WW; Saini S; Slater G; Kaufman JA; Sharma P; Hahn PF
    AJR Am J Roentgenol; 1996 Jan; 166(1):73-7. PubMed ID: 8571910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
    Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
    J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
    Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
    Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
    Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
    AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging.
    Park Y; Choi D; Kim SH; Kim SH; Kim MJ; Lee J; Lim JH; Lee WJ; Lim HK
    Eur J Radiol; 2006 Sep; 59(3):424-31. PubMed ID: 16920312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.
    Small WC; Nelson RC; Bernardino ME
    Magn Reson Imaging; 1993; 11(5):645-54. PubMed ID: 8345779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and spleen enhancement after intravenous injection of carboxydextran magnetite: effect of dose, delay of imaging, and field strength in an ex vivo model.
    Caramella D; Jin XN; Mascalchi M; Agen C; Petruzzi P; Kresse M; Bianucci D; Ceretti E; Semmler W; Bartolozzi C
    MAGMA; 1996; 4(3-4):225-30. PubMed ID: 9220411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.
    Nolte-Ernsting C; Adam G; Bücker A; Berges S; Bjørnerud A; Günther RW
    AJR Am J Roentgenol; 1998 Jul; 171(1):107-13. PubMed ID: 9648772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases.
    Scott J; Ward J; Guthrie JA; Wilson D; Robinson PJ
    Magn Reson Imaging; 2000 Apr; 18(3):297-303. PubMed ID: 10745139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
    Allkemper T; Heindel W; Kooijman H; Ebert W; Tombach B
    Invest Radiol; 2006 Feb; 41(2):97-104. PubMed ID: 16428979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.
    Hudgins PA; Anzai Y; Morris MR; Lucas MA
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):649-56. PubMed ID: 11950660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.